Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Study design: Phase II study, randomized, double-blind, unicentric, two-arm,
placebo-controlled clinical trial. Methods and participants: Patients with Chronic Kidney
Disease G2-G5 with proteinuria without renal replacement therapy, who come to the clinic of
renal health clinic of the Fray Antonio Alcalde civil hospital. As criteria for
non-inclusion, need for dialysis, primary hypothyroidism or pre-existing thyroid disease,
ischemic heart disease in a period less than 6 months, arrhythmia, pregnancy, use of drugs
that interact with synthesis of thyroid hormones, do not accept informed consent, thyroid
stimulating hormone (TSH) <2.5 uiml / L or TSH> 10 uiml / L.